For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Takashi Shoda, President and CEO
(Code no.: 4568, First Section, Tokyo, Osaka, and Nagoya Stock Exchanges)
Please address inquiries to Toshiaki Sai, General Manager,
Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/

Daiichi Sankyo Renames Two Chinese Subsidiaries

Tokyo, July 2, 2009 - Daiichi Sankyo Company, Limited, announced that it has renamed two Chinese subsidiaries that previously operated as Daiichi Pharmaceutical (Beijing) Co., Ltd., and Shanghai Sankyo Pharmaceuticals Co., Ltd.

The renaming is part of ongoing efforts by the Daiichi Sankyo Group to create a unified and consistent global brand.

Please see below for the details of the name changes.



Date of Change: 1st July, 2009